Log In
Print
BCIQ
Print
Print this Print this
 

OTO-104

  Manage Alerts
Collapse Summary General Information
Company Otonomy Inc.
DescriptionSustained-release dexamethasone gel delivered via intratympanic injection
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHearing loss
Indication DetailsTreat acute hearing loss; Treat Meniere's disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today